A new blood test for prostate cancer promises to help monitor patients without an invasive procedure, rapidly revealing whether a sufferer needs urgent treatment. 'We urgently need biomarkers that will help us determine how far along each patient's cancer is, to determine the best course of treatment. Team took blood samples from 25 cancer patients and four healthy volunteers to develop the test. Professor Mark Emberton added: 'The field of liquid biopsies has shown great potential recently to improve the diagnosis and management of cancer patients. 'This could allow targeting of treatment for men at the highest risk of prostate cancer spread.'

Source: Daily Mail March 10, 2020 00:33 UTC